Nanjing Brain Hospital

Running trials

• Recruiting

  A Study of Trontinemab in Cognitively Unimpaired Individuals at Risk for Progression to Symptomatic Alzheimer's Disease

  NCT07717411· Phase 3· Source

• Recruiting

  Efficacy and Safety of BR005-036C Tablets for the Acute Treatment of Migraine in Adults

  NCT07792681· Phase 2/3· Source

• Not yet recruiting

  Long-term Safety of BR005-036C Tablets in the Acute Treatment of Migraine in Adults

  NCT07835152· Phase 3· Source

• Recruiting

  Adaptive DBS for PD

  NCT07635823· Source

• Recruiting

  Donanemab (LY3002813) Trial in Chinese Participants With Cognitively Unimpaired (Preclinical) Alzheimer's Disease

  NCT07571161· Phase 3· Source

• Not yet recruiting

  TIS for Brain Network Modulation and Clinical Efficacy in Parkinson's Disease

  NCT07480317· Source

• Recruiting

  Remote Ischemic Conditioning for Sleep Disturbances and Other Non-motor Symptoms in Parkinson's Disease

  NCT07299240· Source

• Recruiting

  40 Hz Flickering for Insomnia in Parkinson's Disease

  NCT07323121· Source

• Not yet recruiting

  Subthalamic Nucleus Versus Globus Pallidal Internus Deep Brain Stimulation for Parkinson Disease

  NCT07250685· Source

• Recruiting

  A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease

  NCT07174310· Phase 3· Source

• Recruiting

  HD-tDCS for Adolescent Bipolar Depression Targeting S1

  NCT07246044· Source

• Recruiting

  A Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Features, in Participants With Bipolar-I Disorder Taking Lithium, Valproate, or Lamotrigine

  NCT07140913· Phase 3· Source

• Not yet recruiting

  Efficacy and Functional Recovery After Switching From Paliperidone Palmitate Injection to Oral Antipsychotics in Schizophrenia

  NCT07075237· Phase 4· Source

• Active, not recruiting

  A Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease

  NCT07169578· Phase 3· Source

• Recruiting

  Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies

  NCT07177352· Phase 3· Source

• Recruiting

  Lecanemab for Early Onset Familial Alzheimer's Disease

  NCT06883019· Source

• Recruiting

  Evaluate the Efficacy and Safety of TTYP01 Tablets in Adolescents and Children With ASD

  NCT06757504· Phase 2· Source

• Active, not recruiting

  A Study of Remternetug (LY3372993) in Early Alzheimer's Disease (TRAILRUNNER-ALZ 3)

  NCT06653153· Phase 3· Source

• Recruiting

  A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)

  NCT06585787· Phase 3· Source

• Recruiting

  Establishing a Clinical Database and Biobank for Schizophrenia：A Cohort Study

  NCT06123897· Source

• Recruiting

  An Efficacy and Safety Study of Sodium Oligomannate (GV-971) for the Treatment of Alzheimer's Disease

  NCT05908695· Phase 4· Source

• Active, not recruiting

  A Study of Donanemab (LY3002813) in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ 5)

  NCT05508789· Phase 3· Source

• Active, not recruiting

  A Study to Confirm Safety and Efficacy of Lecanemab in Participants With Early Alzheimer's Disease

  NCT03887455· Phase 3· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Alzheimer disease6 recruiting
• Parkinson disease6 recruiting
• Bipolar disorder2 recruiting
• Migraine2 recruiting
• Schizophrenia2 recruiting
• Autism1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Completed

  Development and Preliminary Validation of a Perioperative Pulmonary Rehabilitation Nursing System for Patients With Craniocerebral Tumors

  NCT07571759· Source

• Completed

  Effect of rTMS of the Cerebellum on Parkinson's Disease

  NCT05850598· Source

• Completed

  PERMA-Based Intervention on Negative Emotions, Adherence, and Complications in Postoperative Glioma Patients

  NCT06713395· Source

• Completed

  CONNEX-3: A Study to Test Whether Iclepertin Improves Learning and Memory in People With Schizophrenia

  NCT04860830· Phase 3· Source

• Completed

  Effectiveness and Safety of Directional Deep Brain Stimulation for Parkinson's Disease

  NCT05992701· Source

Trial sites

• Nanjing Brain Hospital3 trials
• Affiliated Nanjing Brain Hospital, Nanjing Medical University1 trial
• Nanjing Brain Hospital15 trials
• Nanjing Brain Hospital (Affiliated Brain Hospital of Nanjing Medical University)1 trial
• Nanjing Brain Hospital, Affiliated to Nanjing Medical University2 trials
• Nanjing Brain Hospital, Nanjing Medical University1 trial
• Nanjing Brain Hospital, The Affiliated Brain Hospital of Nanjing Medical University1 trial
• The Affiliated Brain Hospital of Nanjing Medical University2 trials
• The Affiliated Brain Hospital of Nanjing Medical University, 264 Guangzhou Road2 trials

Conditions

Diseases this institution publishes on or runs trials for.

• Depression59 works · 0 trials
• Schizophrenia44 works · 4 trials
• Bipolar disorder24 works · 2 trials